Aducanumab
-
Controversial Alzheimer’s drug approved in U.S. Where does Canada stand?The U.S. FDA authorization of aducanumab, the first new medication to treat Alzheimer’s disease in 18 years, has drawn a mixed response among the scientific community in Canada.HealthJun 10, 2021
-
U.S. FDA approves 1st new Alzheimer’s drug in nearly 20 yearsIt's the only drug that U.S. regulators have said can likely treat the underlying disease, rather than manage symptoms like anxiety and insomnia.HealthJun 7, 2021
-
Company pushes Alzheimer’s drug amid conflicting resultsAducanumab's developers stopped two studies earlier this year because it didn’t seem to be working, then did a stunning about-face in October and said new results suggest it was effective at a high dose.ScienceDec 6, 2019
![]()
